Setting new standards in information exchange for the pharmaceutical and biotech industry
NYT’s Cover Story on Harnessing the Immune System to Fight Cancer
August 1, 2016
This past weekend, the New York Times cover story featured several patients who have participated in cancer immunotherapy clinical trials and profiled a number of the IO360 speakers. The article gives hope for the future of IO. Immuno-Oncology 360° speaker Dr Jedd Wolchok of Memorial Sloan Kettering Cancer Center commented that “this [immunotherapy] is a fundamental change in the way that we think about cancer therapy.”
The article also features 2017 Immuno-Oncology 360° keynote speaker Dr James Allison of MD Anderson Cancer Center, who discusses the importance of the preclinical work using mouse models that displayed positive results of the antibody he developed to block the checkpoints and launch T-cells against cancer. The antibody, known now as BMS’ Yervoy was further developed for humans and was approved in 2011 to treat advanced melanoma.
To read the full New York Times article visit: http://mobile.nytimes.com/2016/07/31/health/harnessing-the-immune-system-to-fight-cancer.html?_r=0
For more information on Immuno-Oncology 360° visit: http://theconferenceforum.org/conferences/immuno-oncology-360/overview/